Quisel John D
Insider CIK 1586788 · XLRN VP General Counsel & Secretary · GOSS Director · IRON Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-09-23 | 2026-09-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-09-23 | 2026-09-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-16 | 36,000 | — | $0 | 150,120 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2026-09-15 | 2026-09-16 | 36,000 | $1.01 | $36.4K | 262,064 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-16 | 36,000 | — | $0 | 150,120 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2026-09-15 | 2026-09-16 | 36,000 | $1.01 | $36.4K | 262,064 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-18 | 33,000 | — | $0 | 91,586 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-08-17 | 2026-08-18 | 8,400 | $78.11 | $656.1K | 250,664 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-08-17 | 2026-08-18 | 11,888 | $79.84 | $949.1K | 226,064 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-08-17 | 2026-08-18 | 12,712 | $79.20 | $1.01M | 237,952 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2026-08-17 | 2026-08-18 | 33,000 | $13.50 | $445.5K | 259,064 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-18 | 33,000 | — | $0 | 91,586 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-08-17 | 2026-08-18 | 11,888 | $79.84 | $949.2K | 226,064 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-08-17 | 2026-08-18 | 12,712 | $79.20 | $1.01M | 237,952 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-08-17 | 2026-08-18 | 8,400 | $78.11 | $656.1K | 250,664 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2026-08-17 | 2026-08-18 | 33,000 | $13.50 | $445.5K | 259,064 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2026-07-13 | 2026-07-14 | 7,416 | — | $0 | 124,586 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2026-07-13 | 2026-07-14 | 25,584 | — | $0 | 15,791 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-07-13 | 2026-07-14 | 9,704 | $74.27 | $720.7K | 249,360 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2026-07-13 | 2026-07-14 | 7,416 | $13.50 | $100.1K | 259,064 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2026-07-13 | 2026-07-14 | 25,584 | $9.86 | $252.3K | 251,648 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-07-13 | 2026-07-14 | 6,400 | $76.05 | $486.7K | 226,064 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-07-13 | 2026-07-14 | 16,896 | $74.95 | $1.27M | 232,464 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2026-06-18 | 2026-06-23 | 34,000 | — | $0 | 41,375 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-06-18 | 2026-06-23 | 22,927 | $69.92 | $1.60M | 237,137 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-06-18 | 2026-06-23 | 9,522 | $70.70 | $673.2K | 227,615 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-06-18 | 2026-06-23 | 1,551 | $71.61 | $111.1K | 226,064 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2026-06-18 | 2026-06-23 | 34,000 | $9.86 | $335.2K | 260,064 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2026-06-04 | 2026-06-05 | 115,000 | — | $0 | 115,000 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2026-02-17 | 2026-02-17 | 13,264 | $62.86 | $833.8K | 226,064 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2026-02-10 | 2026-02-11 | 82,800 | — | $0 | 82,800 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award | 2026-02-10 | 2026-02-11 | 55,200 | — | $0 | 239,328 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2025-12-19 | 2025-12-19 | 12,300 | — | $0 | 186,120 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2025-12-19 | 2025-12-19 | 12,300 | $1.01 | $12.4K | 184,128 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2025-12-11 | 2025-12-15 | 40,000 | — | $0 | 75,375 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-12-11 | 2025-12-15 | 16,888 | $93.65 | $1.58M | 171,828 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-12-11 | 2025-12-15 | 16,356 | $92.96 | $1.52M | 188,716 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-12-11 | 2025-12-15 | 4,337 | $92.21 | $399.9K | 205,072 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-12-11 | 2025-12-15 | 2,419 | $90.97 | $220.1K | 209,409 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2025-12-11 | 2025-12-15 | 40,000 | $9.86 | $394.4K | 211,828 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2025-09-09 | 2025-09-11 | 10,000 | — | $0 | 198,420 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2025-09-09 | 2025-09-11 | 10,000 | $1.01 | $10.1K | 171,828 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2025-07-09 | 2025-07-11 | 34,800 | — | $0 | 115,375 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-07-09 | 2025-07-11 | 3,593 | $56.20 | $201.9K | 161,828 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-07-09 | 2025-07-11 | 31,207 | $55.23 | $1.72M | 165,421 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2025-07-09 | 2025-07-11 | 34,800 | $9.86 | $343.1K | 196,628 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2025-07-03 | 2025-07-08 | 5,200 | — | $0 | 150,175 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-07-03 | 2025-07-08 | 5,200 | $55.09 | $286.5K | 161,828 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2025-07-03 | 2025-07-08 | 5,200 | $9.86 | $51.3K | 167,028 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2025-06-25 | 2025-06-26 | 115,000 | — | $0 | 115,000 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2025-04-07 | 2025-04-08 | 7,000 | — | $0 | 208,420 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2025-04-07 | 2025-04-08 | 7,000 | $1.01 | $7.1K | 161,828 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-02-18 | 2025-02-20 | 5,574 | $54.58 | $304.2K | 154,828 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2025-02-10 | 2025-02-12 | 117,505 | — | $0 | 117,505 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award | 2025-02-10 | 2025-02-12 | 78,337 | — | $0 | 160,402 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-12-31 | 2025-01-02 | 10,000 | — | $0 | 215,420 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-12-31 | 2025-01-02 | 10,000 | $1.01 | $10.1K | 82,065 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-12-30 | 2025-01-02 | 13,012 | — | $0 | 155,375 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-12-30 | 2025-01-02 | 13,012 | $9.86 | $128.3K | 85,077 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-12-30 | 2025-01-02 | 11,112 | $61.87 | $687.5K | 73,965 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-12-30 | 2025-01-02 | 1,900 | $62.41 | $118.6K | 72,065 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-12-23 | 2024-12-26 | 19,820 | — | $0 | 41,830 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-12-23 | 2024-12-26 | 3,414 | $62.38 | $213.0K | 88,471 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-12-23 | 2024-12-26 | 19,820 | $2.65 | $52.5K | 91,885 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-12-23 | 2024-12-26 | 4,212 | $63.80 | $268.7K | 72,065 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-12-23 | 2024-12-26 | 12,194 | $63.12 | $769.7K | 76,277 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-12-16 | 2024-12-18 | 12,791 | — | $0 | 225,420 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-12-16 | 2024-12-18 | 5,767 | $65.58 | $378.2K | 78,870 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-12-16 | 2024-12-18 | 6,305 | $66.35 | $418.3K | 72,565 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-12-16 | 2024-12-18 | 500 | $67.20 | $33.6K | 72,065 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2024-12-16 | 2024-12-18 | 219 | $64.66 | $14.2K | 84,637 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-12-16 | 2024-12-18 | 12,791 | $1.01 | $12.9K | 84,856 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2024-07-08 | 2024-07-10 | 3,000 | — | $0 | 238,211 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2024-07-08 | 2024-07-10 | 3,000 | $1.01 | $3.0K | 72,065 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2024-06-06 | 2024-06-06 | 115,000 | — | $0 | 115,000 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2024-01-10 | 2024-03-01 | 99,550 | — | $0 | 99,550 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award | 2024-01-10 | 2024-03-01 | 66,365 | — | $0 | 69,065 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2023-12-29 | 2024-01-03 | 2,700 | — | $0 | 241,211 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2023-12-29 | 2024-01-03 | 2,700 | $1.01 | $2.7K | 2,700 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-11-28 | 2023-11-29 | 230,000 | — | $0 | 230,000 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2022-12-29 | 2023-01-03 | 132,002 | — | $0 | 132,002 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-01-02 | 2020-01-03 | 4,242 | $52.52 | $222.8K | 53,316 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-01-02 | 2020-01-03 | 1,600 | $52.51 | $84.0K | 57,558 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-09-10 | 2019-09-10 | 3,584 | $45.23 | $162.1K | 59,158 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2019-07-09 | 2019-07-11 | 1,562 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2019-07-09 | 2019-07-11 | 5,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2019-07-09 | 2019-07-11 | 2,346 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2019-07-09 | 2019-07-11 | 1,562 | $7.12 | $11.1K | 62,742 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2019-07-09 | 2019-07-11 | 5,000 | $3.88 | $19.4K | 58,834 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2019-07-09 | 2019-07-11 | 2,346 | $5.28 | $12.4K | 61,180 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-04-09 | 2019-04-11 | 100 | $45.46 | $4.5K | 53,904 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-04-09 | 2019-04-11 | 3,452 | $44.62 | $154.0K | 54,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-04-09 | 2019-04-11 | 70 | $44.24 | $3.1K | 53,834 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2019-01-25 | 2019-01-29 | 28,500 | — | $0 | 28,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2019-01-25 | 2019-01-29 | 4,800 | — | $0 | 57,456 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-01-02 | 2019-01-04 | 1,309 | $42.32 | $55.4K | 57,289 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-01-02 | 2019-01-04 | 300 | $43.26 | $13.0K | 56,989 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-01-02 | 2019-01-04 | 1,300 | $42.31 | $55.0K | 55,689 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-01-02 | 2019-01-04 | 2,558 | $43.10 | $110.2K | 53,131 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-01-02 | 2019-01-04 | 475 | $43.92 | $20.9K | 52,656 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2018-05-10 | 2018-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2018-05-10 | 2018-05-11 | 2,000 | — | $0 | 58,598 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-04-03 | 2018-04-04 | 1,104 | $38.33 | $42.3K | 56,698 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-04-03 | 2018-04-04 | 100 | $39.16 | $3.9K | 56,598 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2018-03-01 | 2018-03-05 | 28,950 | — | $0 | 28,950 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2018-03-01 | 2018-03-05 | 4,825 | — | $0 | 57,802 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-01-02 | 2018-01-04 | 4,333 | $42.42 | $183.8K | 52,977 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-09-13 | 2017-09-14 | 8 | $38.03 | $304 | 57,310 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-09-12 | 2017-09-14 | 600 | $39.37 | $23.6K | 57,318 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-09-12 | 2017-09-14 | 4,505 | $38.29 | $172.5K | 57,918 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2017-03-02 | 2017-03-14 | 46,300 | — | $0 | 46,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2017-03-02 | 2017-03-14 | 7,900 | — | $0 | 62,423 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-01-04 | 2017-01-06 | 300 | $26.43 | $7.9K | 55,923 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-01-04 | 2017-01-06 | 1,400 | $27.56 | $38.6K | 54,523 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-09-21 | 2016-09-23 | 13,671 | — | $0 | 15,329 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-09-21 | 2016-09-23 | 781 | — | $0 | 1,562 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-09-21 | 2016-09-23 | 11,500 | — | $0 | 5,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-09-21 | 2016-09-23 | 45,952 | $38.05 | $1.75M | 56,223 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-09-21 | 2016-09-23 | 781 | $7.12 | $5.6K | 77,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-09-21 | 2016-09-23 | 13,671 | $24.11 | $329.6K | 90,675 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-09-21 | 2016-09-23 | 11,500 | $3.88 | $44.6K | 102,175 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-09-12 | 2016-09-13 | 5,500 | — | $0 | 16,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-09-12 | 2016-09-13 | 4,688 | — | $0 | 2,343 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-09-12 | 2016-09-13 | 6,250 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-09-12 | 2016-09-13 | 21,438 | $32.14 | $689.0K | 76,223 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-09-12 | 2016-09-13 | 4,688 | $7.12 | $33.4K | 97,661 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-09-12 | 2016-09-13 | 6,250 | $5.28 | $33.0K | 92,973 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-09-12 | 2016-09-13 | 5,500 | $3.88 | $21.3K | 86,723 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2016-03-03 | 2016-03-07 | 30,800 | — | $0 | 30,800 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2016-03-03 | 2016-03-07 | 5,100 | — | $0 | 81,223 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-09-14 | 2015-09-16 | 5,500 | — | $0 | 22,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-09-14 | 2015-09-16 | 4,100 | $33.07 | $135.6K | 77,523 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-09-14 | 2015-09-16 | 5,500 | $3.88 | $21.3K | 81,623 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-09-14 | 2015-09-16 | 1,400 | $34.17 | $47.8K | 76,123 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2015-09-09 | 2015-09-11 | 40,000 | — | $0 | 76,123 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-08-14 | 2015-08-17 | 1,039 | — | $0 | 27,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-08-14 | 2015-08-17 | 4,461 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-08-14 | 2015-08-17 | 4,461 | $5.88 | $26.2K | 40,584 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-08-14 | 2015-08-17 | 2,200 | $31.74 | $69.8K | 36,123 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-08-14 | 2015-08-17 | 1,039 | $3.88 | $4.0K | 41,623 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-08-14 | 2015-08-17 | 3,300 | $30.22 | $99.7K | 38,323 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-07-30 | 2015-08-03 | 7,527 | — | $0 | 2,346 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-07-30 | 2015-08-03 | 5,895 | — | $0 | 6,250 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-07-30 | 2015-08-03 | 7,527 | $5.28 | $39.7K | 30,228 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-07-30 | 2015-08-03 | 5,895 | $5.28 | $31.1K | 36,123 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-07-14 | 2015-07-16 | 5,500 | — | $0 | 4,461 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-07-14 | 2015-07-16 | 5,500 | $5.88 | $32.3K | 28,201 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-07-14 | 2015-07-16 | 5,500 | $30.00 | $165.0K | 22,701 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-06-17 | 2015-06-18 | 7,701 | — | $0 | 28,539 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-06-17 | 2015-06-18 | 7,701 | $3.88 | $29.9K | 22,701 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-06-15 | 2015-06-16 | 5,500 | — | $0 | 9,961 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-06-15 | 2015-06-16 | 5,500 | $5.88 | $32.3K | 20,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-06-15 | 2015-06-16 | 5,500 | $31.13 | $171.2K | 15,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-05-14 | 2015-05-18 | 5,500 | — | $0 | 15,461 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-05-14 | 2015-05-18 | 5,500 | $5.88 | $32.3K | 20,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-05-14 | 2015-05-18 | 3,900 | $31.81 | $124.1K | 15,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-05-14 | 2015-05-18 | 1,600 | $31.06 | $49.7K | 18,900 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-03-16 | 2015-03-17 | 1,461 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-03-16 | 2015-03-17 | 4,039 | — | $0 | 20,961 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-03-16 | 2015-03-17 | 1,461 | $5.88 | $8.6K | 16,461 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-03-16 | 2015-03-17 | 4,039 | $5.88 | $23.7K | 20,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-16 | 2015-03-17 | 5,280 | $40.67 | $214.7K | 15,220 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-16 | 2015-03-17 | 220 | $41.20 | $9.1K | 15,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-03-13 | 2015-03-17 | 4,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-03-13 | 2015-03-17 | 4,000 | $5.08 | $20.3K | 19,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-13 | 2015-03-17 | 800 | $42.05 | $33.6K | 15,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-13 | 2015-03-17 | 3,200 | $41.28 | $132.1K | 15,800 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-03-04 | 2015-03-06 | 2,000 | — | $0 | 4,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-03-04 | 2015-03-06 | 2,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-03-04 | 2015-03-06 | 5,500 | — | $0 | 1,461 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 2,699 | $40.65 | $109.7K | 16,301 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-03-04 | 2015-03-06 | 2,000 | $5.08 | $10.2K | 19,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 1,300 | $41.50 | $54.0K | 15,001 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 1 | $42.07 | $42 | 15,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-03-04 | 2015-03-06 | 5,500 | $5.88 | $32.3K | 20,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 4,333 | $40.34 | $174.8K | 16,167 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 1,066 | $41.77 | $44.5K | 15,101 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 101 | $42.06 | $4.2K | 15,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-03-04 | 2015-03-06 | 2,000 | $1.80 | $3.6K | 17,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-01-14 | 2015-01-16 | 2,438 | — | $0 | 6,961 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-01-14 | 2015-01-16 | 1,500 | — | $0 | 6,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-01-14 | 2015-01-16 | 1,562 | — | $0 | 12,145 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-01-14 | 2015-01-16 | 500 | — | $0 | 2,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-01-14 | 2015-01-16 | 3,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-01-14 | 2015-01-16 | 5,500 | $40.12 | $220.7K | 15,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-01-14 | 2015-01-16 | 2,438 | $5.88 | $14.3K | 20,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-01-14 | 2015-01-16 | 3,500 | $39.85 | $139.5K | 15,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-01-14 | 2015-01-16 | 1,562 | $5.28 | $8.2K | 16,562 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-01-14 | 2015-01-16 | 500 | $40.62 | $20.3K | 15,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-01-14 | 2015-01-16 | 3,500 | $0.92 | $3.2K | 18,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-01-14 | 2015-01-16 | 500 | $1.80 | $900 | 19,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-01-14 | 2015-01-16 | 1,500 | $5.08 | $7.6K | 18,062 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2015-01-08 | 2015-01-09 | 41,000 | — | $0 | 41,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-12-17 | 2014-12-19 | 15,000 | — | $0 | 36,240 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-12-17 | 2014-12-19 | 15,000 | $3.88 | $58.2K | 15,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-12-12 | 2014-12-16 | 4,000 | — | $0 | 3,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-12-12 | 2014-12-16 | 4,000 | $0.92 | $3.7K | 4,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-12-12 | 2014-12-16 | 2,500 | $41.72 | $104.3K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-12-12 | 2014-12-16 | 1,500 | $40.72 | $61.1K | 2,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-11-14 | 2014-11-18 | 4,000 | — | $0 | 7,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-11-14 | 2014-11-18 | 675 | $34.72 | $23.4K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-11-14 | 2014-11-18 | 3,325 | $33.24 | $110.5K | 675 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-11-14 | 2014-11-18 | 4,000 | $0.92 | $3.7K | 4,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-11-12 | 2014-11-14 | 3,101 | — | $0 | 9,399 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-11-12 | 2014-11-14 | 1,899 | — | $0 | 7,031 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-11-12 | 2014-11-14 | 1,957 | $32.42 | $63.4K | 3,043 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-11-12 | 2014-11-14 | 3,043 | $33.60 | $102.2K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-11-12 | 2014-11-14 | 3,101 | $5.88 | $18.2K | 3,101 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-11-12 | 2014-11-14 | 1,899 | $7.12 | $13.5K | 5,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-10-14 | 2014-10-16 | 4,000 | — | $0 | 11,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-10-14 | 2014-10-16 | 4,000 | $0.92 | $3.7K | 4,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-10-14 | 2014-10-16 | 4,000 | $29.02 | $116.1K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-09-30 | 2014-10-01 | 3,430 | — | $0 | 13,707 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-09-30 | 2014-10-01 | 3,570 | — | $0 | 8,930 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-09-30 | 2014-10-01 | 7,000 | $30.01 | $210.1K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-09-30 | 2014-10-01 | 3,430 | $5.28 | $18.1K | 3,430 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-09-30 | 2014-10-01 | 3,570 | $7.12 | $25.4K | 7,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-09-12 | 2014-09-12 | 2,000 | — | $0 | 15,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-09-12 | 2014-09-12 | 2,000 | $25.43 | $50.9K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-09-12 | 2014-09-12 | 2,000 | $0.92 | $1.8K | 2,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-08-14 | 2014-08-15 | 3,137 | — | $0 | 9,873 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-08-14 | 2014-08-15 | 2,000 | — | $0 | 17,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-08-14 | 2014-08-15 | 7,863 | — | $0 | 17,137 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-08-14 | 2014-08-15 | 11,000 | $30.02 | $330.2K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-08-14 | 2014-08-15 | 2,000 | $0.92 | $1.8K | 2,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-08-14 | 2014-08-15 | 2,000 | $29.79 | $59.6K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-08-14 | 2014-08-15 | 3,137 | $5.28 | $16.6K | 3,137 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-08-14 | 2014-08-15 | 7,863 | $5.28 | $41.5K | 11,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-07-14 | 2014-07-16 | 3,000 | — | $0 | 13,010 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-07-14 | 2014-07-16 | 2,000 | — | $0 | 19,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-07-14 | 2014-07-16 | 2,000 | $0.92 | $1.8K | 2,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-07-14 | 2014-07-16 | 1,100 | $28.70 | $31.6K | 900 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-07-14 | 2014-07-16 | 3,000 | $5.28 | $15.8K | 3,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-07-14 | 2014-07-16 | 3,000 | $30.12 | $90.4K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-07-14 | 2014-07-16 | 900 | $29.71 | $26.7K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2014-07-01 | 2014-07-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-06-13 | 2014-06-17 | 4,260 | — | $0 | 51,240 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-06-13 | 2014-06-17 | 2,740 | — | $0 | 16,010 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-06-13 | 2014-06-17 | 2,000 | — | $0 | 21,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-06-13 | 2014-06-17 | 2,700 | $34.13 | $92.2K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-06-13 | 2014-06-17 | 6,300 | $33.86 | $213.3K | 2,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-06-13 | 2014-06-17 | 2,000 | $0.92 | $1.8K | 2,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-06-13 | 2014-06-17 | 4,260 | $3.88 | $16.5K | 6,260 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-06-13 | 2014-06-17 | 2,740 | $5.28 | $14.5K | 9,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-05-19 | 2014-05-21 | 7,000 | — | $0 | 55,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-05-19 | 2014-05-21 | 2,000 | — | $0 | 23,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-05-19 | 2014-05-21 | 6,100 | $31.29 | $190.9K | 900 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-05-19 | 2014-05-21 | 2,000 | $0.92 | $1.8K | 2,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-05-19 | 2014-05-21 | 2,000 | $31.49 | $63.0K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-05-19 | 2014-05-21 | 7,000 | $3.88 | $27.2K | 7,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-05-19 | 2014-05-21 | 900 | $32.20 | $29.0K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-04-22 | 2014-04-24 | 2,000 | — | $0 | 25,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-04-22 | 2014-04-24 | 2,000 | $0.92 | $1.8K | 2,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-04-22 | 2014-04-24 | 1,500 | $35.75 | $53.6K | 500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-04-22 | 2014-04-24 | 500 | $36.13 | $18.1K | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2013-12-05 | 2013-12-09 | 29,000 | — | $0 | 29,000 | SEC↗ |